Bisgard K M, Rhodes P, Hardy I R, Litkina I L, Filatov N N, Monisov A A, Wharton M
Epidemiology and Surveillance Division, Centers for Disease Control and Prevention, Atlanta, GA 30083, USA.
J Infect Dis. 2000 Feb;181 Suppl 1:S184-7. doi: 10.1086/315562.
Prior to the completion of this and other studies, low effectiveness of diphtheria toxoid-containing vaccine was suspected to be a major contributing factor to the diphtheria epidemic that began in the Russian Federation in 1990. A vaccine effectiveness study was done in Moscow by enrolling physician-diagnosed cases and 10 control subjects per case. Controls were matched to cases by age (+/-3 months) and clinic registration. Vaccination history was abstracted from a standardized form for case-patients and from clinic vaccination records for control subjects. Two hundred seventeen case-patients and 2169 matched controls were included in the study. Most controls (92%) had received three or more doses of a diphtheria toxoid vaccine, compared with 72% of case-patients. The vaccine effectiveness for three or more doses was 97% (95% confidence interval: 94.3-98.4). Low vaccine effectiveness was not a contributing factor to the diphtheria epidemic in the Russian Federation. To control and prevent diphtheria epidemics, it is necessary to achieve and maintain high vaccination coverage with three or more doses of diphtheria toxoid among adults and children.
在本研究及其他研究完成之前,含白喉类毒素疫苗的低效被怀疑是导致1990年在俄罗斯联邦开始的白喉疫情的一个主要因素。在莫斯科开展了一项疫苗效力研究,纳入经医生诊断的病例,每个病例匹配10名对照对象。对照对象按年龄(±3个月)和诊所登记情况与病例进行匹配。从病例患者的标准化表格以及对照对象的诊所疫苗接种记录中提取疫苗接种史。该研究纳入了217例病例患者和2169名匹配的对照对象。大多数对照对象(92%)接种了三剂或更多剂白喉类毒素疫苗,相比之下,病例患者中这一比例为72%。接种三剂或更多剂疫苗的效力为97%(95%置信区间:94.3 - 98.4)。疫苗低效并非俄罗斯联邦白喉疫情的一个促成因素。为了控制和预防白喉疫情,有必要在成人和儿童中实现并维持三剂或更多剂白喉类毒素的高接种覆盖率。